• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎 BA.1 导致 SARS-CoV-2 复制减少但干扰素抵抗增强。

Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1.

机构信息

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Institute of General Physiology, Ulm University Medical Center, Ulm, Germany.

出版信息

Life Sci Alliance. 2023 Mar 28;6(6). doi: 10.26508/lsa.202201745. Print 2023 Jun.

DOI:10.26508/lsa.202201745
PMID:36977594
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10053418/
Abstract

The IFN system constitutes a powerful antiviral defense machinery. Consequently, effective IFN responses protect against severe COVID-19 and exogenous IFNs inhibit SARS-CoV-2 in vitro. However, emerging SARS-CoV-2 variants of concern (VOCs) may have evolved reduced IFN sensitivity. Here, we determined differences in replication and IFN susceptibility of an early SARS-CoV-2 isolate (NL-02-2020) and the Alpha, Beta, Gamma, Delta, and Omicron VOCs in Calu-3 cells, iPSC-derived alveolar type-II cells (iAT2) and air-liquid interface (ALI) cultures of primary human airway epithelial cells. Our data show that Alpha, Beta, and Gamma replicated to similar levels as NL-02-2020. In comparison, Delta consistently yielded higher viral RNA levels, whereas Omicron was attenuated. All viruses were inhibited by type-I, -II, and -III IFNs, albeit to varying extend. Overall, Alpha was slightly less sensitive to IFNs than NL-02-2020, whereas Beta, Gamma, and Delta remained fully sensitive. Strikingly, Omicron BA.1 was least restricted by exogenous IFNs in all cell models. Our results suggest that enhanced innate immune evasion rather than higher replication capacity contributed to the effective spread of Omicron BA.1.

摘要

IFN 系统构成了强大的抗病毒防御机制。因此,有效的 IFN 反应可预防严重的 COVID-19,外源性 IFN 可抑制 SARS-CoV-2 的体外复制。然而,新兴的 SARS-CoV-2 关注变异株(VOCs)可能已经进化出对 IFN 的敏感性降低。在这里,我们确定了 Calu-3 细胞、iPSC 衍生的肺泡 II 型细胞(iAT2)和原代人气道上皮细胞的气液界面(ALI)培养物中早期 SARS-CoV-2 分离株(NL-02-2020)与 Alpha、Beta、Gamma、Delta 和 Omicron VOC 之间在复制和 IFN 敏感性方面的差异。我们的数据表明,Alpha、Beta 和 Gamma 的复制水平与 NL-02-2020 相似。相比之下,Delta 始终产生更高的病毒 RNA 水平,而 Omicron 则减弱。所有病毒均被 I 型、II 型和 III 型 IFN 抑制,尽管抑制程度不同。总体而言,Alpha 对 IFN 的敏感性略低于 NL-02-2020,而 Beta、Gamma 和 Delta 仍然完全敏感。值得注意的是,在所有细胞模型中,Omicron BA.1 对外源 IFN 的限制最小。我们的结果表明,增强的先天免疫逃避而不是更高的复制能力导致了 Omicron BA.1 的有效传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/2c3a1bf53c23/LSA-2022-01745_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/8d1c3e94b81c/LSA-2022-01745_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/b94a66b69685/LSA-2022-01745_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/9a8641e32c16/LSA-2022-01745_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/6e2f1b6f7932/LSA-2022-01745_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/c8a129a71aea/LSA-2022-01745_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/eb9e51e3c3e7/LSA-2022-01745_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/2c3a1bf53c23/LSA-2022-01745_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/8d1c3e94b81c/LSA-2022-01745_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/b94a66b69685/LSA-2022-01745_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/9a8641e32c16/LSA-2022-01745_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/6e2f1b6f7932/LSA-2022-01745_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/c8a129a71aea/LSA-2022-01745_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/eb9e51e3c3e7/LSA-2022-01745_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b13e/10053418/2c3a1bf53c23/LSA-2022-01745_Fig4.jpg

相似文献

1
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1.奥密克戎 BA.1 导致 SARS-CoV-2 复制减少但干扰素抵抗增强。
Life Sci Alliance. 2023 Mar 28;6(6). doi: 10.26508/lsa.202201745. Print 2023 Jun.
2
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
3
SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.SARS-CoV-2 关切变种劫持 IFITM2 以在人肺细胞中高效复制。
J Virol. 2022 Jun 8;96(11):e0059422. doi: 10.1128/jvi.00594-22. Epub 2022 May 11.
4
Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating.在原代人鼻腔培养物中比较关注的 SARS-CoV-2 变异株,表明德尔塔变异株具有最高的细胞病变效应,而奥密克戎变异株复制速度最快。
mBio. 2024 Apr 10;15(4):e0312923. doi: 10.1128/mbio.03129-23. Epub 2024 Mar 13.
5
SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant.SARS-CoV-2 的 Alpha、Beta、Delta 和奥密克戎变异株与早期大流行变异株相比,宿主细胞干扰素反应较慢。
Front Immunol. 2022 Sep 30;13:1016108. doi: 10.3389/fimmu.2022.1016108. eCollection 2022.
6
Inhibition of SARS-CoV-2 by type I and type III interferons.I 型和 III 型干扰素对 SARS-CoV-2 的抑制作用。
J Biol Chem. 2020 Oct 9;295(41):13958-13964. doi: 10.1074/jbc.AC120.013788. Epub 2020 Jun 25.
7
SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?SARS-CoV-2 逃避干扰素系统:我们能否恢复其有效性?
Int J Mol Sci. 2023 May 27;24(11):9353. doi: 10.3390/ijms24119353.
8
Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.Ⅰ型和Ⅲ型干扰素限制 SARS-CoV-2 感染人呼吸道上皮细胞。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00985-20.
9
Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.人肠上皮细胞中 SARS-CoV-2 对 III 型干扰素的敏感性增加。
J Virol. 2022 Apr 13;96(7):e0170521. doi: 10.1128/jvi.01705-21. Epub 2022 Mar 9.
10
Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection.奥密克戎诱导的干扰素信号传导可预防甲型H1N1和H5N1流感病毒感染。
J Med Virol. 2023 Mar;95(3):e28686. doi: 10.1002/jmv.28686.

引用本文的文献

1
Replication differences of SARS-CoV-2 lineages may arise from unique RNA replication characteristics and nucleocapsid protein expression.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系的复制差异可能源于独特的RNA复制特征和核衣壳蛋白表达。
Front Cell Infect Microbiol. 2025 Jul 11;15:1582137. doi: 10.3389/fcimb.2025.1582137. eCollection 2025.
2
Mutation T9I in Envelope confers autophagy resistance to SARS-CoV-2 Omicron.包膜蛋白中的T9I突变赋予了新冠病毒奥密克戎变异株自噬抗性。
iScience. 2025 Jun 20;28(7):112974. doi: 10.1016/j.isci.2025.112974. eCollection 2025 Jul 18.
3
Sensing of SARS-CoV-2-infected cells by plasmacytoid dendritic cells is modulated via an interplay between CD54/ICAM-1 and CD11a/LFA-1 α integrin.

本文引用的文献

1
Early Treatment with Pegylated Interferon Lambda for Covid-19.聚乙二醇干扰素 λ 早期治疗 COVID-19。
N Engl J Med. 2023 Feb 9;388(6):518-528. doi: 10.1056/NEJMoa2209760.
2
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的奥密克戎变体对抗病毒I型干扰素反应的抵抗力增强。
PNAS Nexus. 2022 May 23;1(2):pgac067. doi: 10.1093/pnasnexus/pgac067. eCollection 2022 May.
3
Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity.
浆细胞样树突状细胞对感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的细胞的感知通过CD54/细胞间黏附分子-1(ICAM-1)和CD11a/淋巴细胞功能相关抗原-1(LFA-1)α整合素之间的相互作用来调节。
J Virol. 2025 Feb 25;99(2):e0123524. doi: 10.1128/jvi.01235-24. Epub 2025 Jan 13.
4
Association between sore throat and early immune responses against COVID-19 before and after the emergence of the Omicron variant.奥密克戎变异株出现前后,喉咙痛与针对新冠病毒的早期免疫反应之间的关联。
Ann Transl Med. 2024 Oct 20;12(5):87. doi: 10.21037/atm-24-36. Epub 2024 Sep 19.
5
Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses.严重急性呼吸综合征冠状病毒2与甲型流感病毒之间的病毒干扰
PLoS Pathog. 2024 Jul 22;20(7):e1012017. doi: 10.1371/journal.ppat.1012017. eCollection 2024 Jul.
6
Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.鼻上皮细胞中的干扰素信号转导可区分致死性和普通感冒冠状病毒,并介导病毒清除。
Proc Natl Acad Sci U S A. 2024 May 21;121(21):e2402540121. doi: 10.1073/pnas.2402540121. Epub 2024 May 17.
7
Humoral Immune Response to SARS-CoV-2 Spike Protein Receptor-Binding Motif Linear Epitopes.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合基序线性表位的体液免疫反应
Vaccines (Basel). 2024 Mar 22;12(4):342. doi: 10.3390/vaccines12040342.
8
SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.SARS-CoV-2 nsp15 内切核酸酶拮抗 dsRNA 诱导的抗病毒信号。
Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2320194121. doi: 10.1073/pnas.2320194121. Epub 2024 Apr 3.
9
Impact of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review.严重急性呼吸综合征冠状病毒2刺突蛋白对固有免疫系统的影响:综述
Cureus. 2024 Mar 26;16(3):e57008. doi: 10.7759/cureus.57008. eCollection 2024 Mar.
10
Upping the ante: enhanced expression of interferon-antagonizing ORF6 and ORF9b proteins by SARS-CoV-2 variants of concern.提高赌注:SARS-CoV-2 关切变异株增强了干扰素拮抗 ORF6 和 ORF9b 蛋白的表达。
Curr Opin Microbiol. 2024 Jun;79:102454. doi: 10.1016/j.mib.2024.102454. Epub 2024 Mar 21.
干扰素-λ 治疗可加速 SARS-CoV-2 清除,尽管与年龄相关的 T 细胞免疫诱导延迟。
Nat Commun. 2022 Nov 16;13(1):6992. doi: 10.1038/s41467-022-34709-4.
4
Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2.SARS-CoV-2 奥密克戎变异株 BA.1 和 BA.2 中刺突感染力、加工和中和的决定因素。
Cell Host Microbe. 2022 Sep 14;30(9):1255-1268.e5. doi: 10.1016/j.chom.2022.07.006. Epub 2022 Jul 18.
5
Interferon resistance of emerging SARS-CoV-2 variants.新兴 SARS-CoV-2 变异株的干扰素耐药性。
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2203760119. doi: 10.1073/pnas.2203760119. Epub 2022 Jul 22.
6
Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.黏蛋白 MUC5AC 和 MUC5B 可变地包装在相同和不同的分泌颗粒中。
Am J Respir Crit Care Med. 2022 Nov 1;206(9):1081-1095. doi: 10.1164/rccm.202202-0309OC.
7
SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.SARS-CoV-2 关切变种劫持 IFITM2 以在人肺细胞中高效复制。
J Virol. 2022 Jun 8;96(11):e0059422. doi: 10.1128/jvi.00594-22. Epub 2022 May 11.
8
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment.严重急性呼吸综合征冠状病毒2型奥密克戎变异株病毒分离株对干扰素治疗高度敏感。
Cell Discov. 2022 May 10;8(1):42. doi: 10.1038/s41421-022-00408-z.
9
Interferon antagonists encoded by SARS-CoV-2 at a glance.一眼看懂 SARS-CoV-2 编码的干扰素拮抗剂。
Med Microbiol Immunol. 2023 Apr;212(2):125-131. doi: 10.1007/s00430-022-00734-9. Epub 2022 Apr 2.
10
Inhibition of calcium-triggered secretion by hydrocarbon-stapled peptides.烃 stapled 肽抑制钙触发的分泌。
Nature. 2022 Mar;603(7903):949-956. doi: 10.1038/s41586-022-04543-1. Epub 2022 Mar 23.